Kyntra Bio Other Long Term Liabilities (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

9.35 +0.22 (+2.41%) USD | NASDAQ | Jan 14, 12:25

View Other Long Term Liabilities (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	--
Theravance Biopharma, Inc.	Upgrade
Myomo, Inc.	--